Northwestern Brain Tumor Institute
Types of Brain Tumors   |   Online and Community Resources   |   Glossary of Terms

There are many different types of benign and malignant brain and spinal tumors. They are usually categorized by either the type of cell where the tumor begins or the area of the brain or spine where they occur. Ask your treatment team for more information about a specific type of brain or spinal tumor. Be aware that different names are sometimes used for the same type of tumor; the most common types include the following:
Robert H. Lurie Comprehensive Cancer Center   Gliomas Robert H. Lurie Comprehensive Cancer Center   Craniopharyngioma
Robert H. Lurie Comprehensive Cancer Center   Germinomas
Robert H. Lurie Comprehensive 	Cancer Center   Medulloblastomas
Robert H. Lurie Comprehensive Cancer Center   Meningiomas
Robert H. Lurie Comprehensive Cancer Center   Metastatic tumors
Robert H. Lurie Comprehensive Cancer Center   Pituitary tumors
Robert H. Lurie Comprehensive Cancer Center   Primary Central Nervous System Lymphoma
Robert H. Lurie Comprehensive Cancer Center   Primitive neuroectodermal tumors (PNET)
Robert H. Lurie Comprehensive Cancer Center   Schwannomas
Robert H. Lurie Comprehensive Cancer Center   Pineal region tumors
Low grade astrocytoma
This is a tumor which is from the astrocyte cell and is slow growing. These are slow growing cells and are Graded I-II but may progress to Grade III or IV. These are usually found in young adults.

Childhood Brain Tumors
Pediatric brain tumors affect nearly 1,500 to 2,000 children in the U.S. every year. They are diagnosed most often between the ages of three and eight, but can occur at any age.

Children with brain tumors are diagnosed and treated by our partner, Children's Memorial Hospital's Falk Brain Tumor Center. One of the first institutions in the country to develop a cohesive, multidisciplinary program for brain tumor treatment, Children's Memorial treats over 67 percent of children in the Chicago area who are newly diagnosed with this condition, and treat many additional patients with recurrent disease.

Northwestern Brain Tumor Institute